BLCO:NYSE
Bausch + Lomb Corp
$17.25
arrow_upward
+0.41%(+0.070) 1D
Oct 7, 10:48:07 AM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BLCO...
Open
$17.43
High
$17.44
Low
$17.23
Mkt. cap
6.16B
Avg. vol.
382.28K
Volume
30.41K
52-wk high
$18.92
52-wk low
$13.76
EPS
-$0.48
Beta
0.56
Shares outstanding
357.16M
No. of employees
13K
Open
$17.43
High
$17.44
Low
$17.23
Mkt. cap
6.16B
Avg. vol.
382.28K
Volume
30.41K
52-wk high
$18.92
52-wk low
$13.76
EPS
-$0.48
Beta
0.56
Shares outstanding
357.16M
No. of employees
13K
News stories
From web sources and news partners
AD HOC NEWS
·
12 hours ago
Bausch + Lomb stock gets BL1243 update after FDA meeting
TipRanks
·
16 hours ago
Bausch + Lomb Prepares Oral Dry AMD Drug Candidate for Clinical Launch in 2027
Kalkine Media
·
16 hours ago
Why Is SeeLyra Approval Important For Bausch + Lomb (TSX:BLCO)?
Stock Titan
·
18 hours ago
A possible medicine to take by mouth for macular degeneration is planned for 2027 testing
About Bausch + Lomb Corp
CEO-
Employees13K
Founded1853
HeadquartersVaughan, Ontario, Canada
SectorMedical device
Websitebausch.com